No abstract available
MeSH terms
-
Aged
-
Aged, 80 and over
-
Brentuximab Vedotin
-
Humans
-
Immunoconjugates / adverse effects
-
Immunoconjugates / therapeutic use*
-
Ki-1 Antigen / immunology*
-
Lymphoma, T-Cell, Cutaneous / drug therapy*
-
Lymphoma, T-Cell, Cutaneous / immunology*
-
Male
Substances
-
Immunoconjugates
-
Ki-1 Antigen
-
Brentuximab Vedotin